Compile Data Set for Download or QSAR
Report error Found 125 Enz. Inhib. hit(s) with all data for entry = 10939
TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580014BDBM580014(US11485736, Compound Table 2.23)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580015BDBM580015(US11485736, Compound Table 2.24)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580012BDBM580012(US11485736, Compound Table 2.21)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580013BDBM580013(US11485736, Compound Table 2.22)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580018BDBM580018(US11485736, Compound Table 3.2)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580019BDBM580019(US11485736, Compound Table 3.3)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580016BDBM580016(US11485736, Compound Table 2.25)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580017BDBM580017(US11485736, Compound Table 3.1)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580087BDBM580087(US11485736, Compound TABLE 4.5)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580020BDBM580020(US11485736, Compound Table 3.4)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580021BDBM580021(US11485736, Compound Table 3.5)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580010BDBM580010(US11485736, Compound Table 2.19)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580011BDBM580011(US11485736, Compound Table 2.20)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580009BDBM580009(US11485736, Compound Table 2.18)
Affinity DataIC50: 10nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580086BDBM580086(US11485736, Compound TABLE 4.4)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580084BDBM580084(US11485736, Compound TABLE 4.2)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580085BDBM580085(US11485736, Compound TABLE 4.3)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580090BDBM580090(US11485736, Compound TABLE 4.8)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580091BDBM580091(US11485736, Compound TABLE 4.9)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580088BDBM580088(US11485736, Compound TABLE 4.6)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580089BDBM580089(US11485736, Compound TABLE 4.7)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580062BDBM580062(US11485736, Compound Table 3.46)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580063BDBM580063(US11485736, Compound Table 3.47)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580060BDBM580060(US11485736, Compound Table 3.44)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580061BDBM580061(US11485736, Compound Table 3.45)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580064BDBM580064(US11485736, Compound Table 3.48)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580065BDBM580065(US11485736, Compound Table 3.49)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580110BDBM580110(US11485736, Compound TABLE 4.28)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580111BDBM580111(US11485736, Compound TABLE 4.29)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580109BDBM580109(US11485736, Compound TABLE 4.27)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580112BDBM580112(US11485736, Compound TABLE 4.30)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580005BDBM580005(US11485736, Compound Table 2.14 | US11485736, Comp...)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580094BDBM580094(US11485736, Compound TABLE 4.12)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580095BDBM580095(US11485736, Compound TABLE 4.13)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580092BDBM580092(US11485736, Compound TABLE 4.10)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580093BDBM580093(US11485736, Compound TABLE 4.11)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580098BDBM580098(US11485736, Compound TABLE 4.16)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580099BDBM580099(US11485736, Compound TABLE 4.17)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580096BDBM580096(US11485736, Compound TABLE 4.14)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580097BDBM580097(US11485736, Compound TABLE 4.15)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580102BDBM580102(US11485736, Compound TABLE 4.20)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580103BDBM580103(US11485736, Compound TABLE 4.21 | US11485736, Comp...)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580100BDBM580100(US11485736, Compound TABLE 4.18)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580101BDBM580101(US11485736, Compound TABLE 4.19)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580106BDBM580106(US11485736, Compound TABLE 4.24)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580107BDBM580107(US11485736, Compound TABLE 4.25)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580103BDBM580103(US11485736, Compound TABLE 4.21 | US11485736, Comp...)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580022BDBM580022(US11485736, Compound Table 3.6)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580023BDBM580023(US11485736, Compound Table 3.7)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Ksq Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 580026BDBM580026(US11485736, Compound Table 3.10)
Affinity DataIC50: 55nMAssay Description:Deubiquitinase activity was measured using ubiquitin-rhodamine 110 as a substrate. Cleavage of the amide bond between rhodamine and the c-terminal gl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
US Patent

Displayed 1 to 50 (of 125 total ) | Next | Last >>
Jump to: